CRISPR/Cas9 deletions induce adverse on-target genomic effects

By | April 27, 2022
Researchers utilized a CRISPR/Cas9 system to evaluate the usage of tRNA by deleting two tRNA genes from the genomes of hyper hepatocellular carcinoma and human near-haploid chronic myeloid leukemia cells.